Clinical Trial Update: JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for JMKX000189 in moderate to severe active systemic lupus erythematosus is reported with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• JMKX000189

Snippet

Sponsor: Jemincare | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: UNKNOWN